Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.

@article{Packer1990CalciumCB,
  title={Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.},
  author={M. Packer},
  journal={Circulation},
  year={1990},
  volume={82 6},
  pages={
          2254-7
        }
}
  • M. Packer
  • Published 1990
  • Medicine
  • Circulation
  • oncerns have been raised about safety of calcium channel blockers in patients with heart failure since their introduction into cardiovascular medicine more than 25 years ago. By inhibiting the influx of calcium into myocardial cells, calcium channel-blocking drugs can depress contractility in both experimental systems and the clinical setting. The magnitude of this effect is enhanced when these drugs are combined with other negative inotropic agents (e.g., ,8-blockers) or when they are… CONTINUE READING
    117 Citations

    Topics from this paper

    Evolving Role of Calcium Channel Blockers in Heart Failure
    • 9
    Calcium channel blockers in heart failure.
    • 45
    Calcium Antagonist Use in Congestive Heart Failure: Still a Bridge Too Far?
    • R. Piepho
    • Medicine
    • Journal of clinical pharmacology
    • 1995
    • 6
    Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: Focus on felodipine
    • 12
    Safety of calcium antagonists in patients with congestive heart failure.
    • S. Katz
    • Medicine
    • Clinical therapeutics
    • 1997
    • 7

    References

    SHOWING 1-10 OF 38 REFERENCES
    Efficacy of felodipine in congestive heart failure.
    • 54
    • PDF